The 35th CINP World Congress of Neuropsychopharmacology
2024年5月23日〜5月26日Tokyo International Forum
当該イベント内で検索します。
検索するThe 35th CINP World Congress of Neuropsychopharmacology
2024年5月23日〜5月26日Tokyo International Forum
当該イベント内で検索します。
検索する検索結果(1,104)
[PL1]Alcohol Use Disorder: The Gain in the Brain is in the Emotional Pain and Implications for Treatment
*George Koob1(1. Director, National Institute on Alcohol Abuse and Alcoholism)
[PL2]Spirit of Drug Discovery
*Haruo Naito1(1. Eisai Co., Ltd.)
[PL3]Cannabis, the Endocannabinoid System, and Mood Disorders
*Gabriella Gobbi1(1. McGill University)
[PL4]Challenges and Opportunities in Mental Health Research
*Joshua Gordon1(1. National Institute of Mental Health)
[PL5]Brains on fire? The autoimmune basis of severe mental illness
*Belinda Lennox1(1. University of Oxford)
[PL6]The pharmacological treatment of schizophrenia across the life cycle
*W. Wolfgang Fleischhacker1(1. Medical University Innsbruck)
[PL7]Transmission of Misfolded Proteins in Neurodegenerative Disorders: A Common Mechanism of Disease Progression
*Virginia Man-Yee Lee1(1. University of Pennsylvania)
[ME1-1]TBA
*Zhen Wang1(1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine)
[ME1-2]TBA
*Tomohiro Nakao1(1. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
[ME2-1]TBA
*João Luciano De Quevedo
[ME2-2]TBA
*Pedro Schmidt Do Prado Lima
[AW1-1]Gender difference of transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer’s disease: A randomized, double-blind, placebo-controlled trial
*Chieh-Hsin Lin1,2,3, Hsien-Yuan Lane3, Shi-Heng Wang(1. Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Taiwan, 2. School of Medicine, Chang Gung University, Taiwan, 3. Graduate Institute of Biomedical Sciences, China Medical University, Taiwan)
[AW1-2]Glutamatergic dysfunction in dorsal striatum underlies compulsive eating in an animal model of binge eating
*Robyn Mary Brown1,2, Diana Sketriene 1,2, Cherry Mao 2, Andrew John Lawrence 2, Yan Li 1, Christina Milleniaputri Suhartono1(1. Department of Biochemistry and Pharmacology, University of Melbourne, Victoria, Australia , 2. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia )
[AW1-3]Initial data implicating the use of ketamine as a targeted treatment for depression in Parkinson’s disease
Yanghong Yang1, Mika Naganawa1, Mina Ansari1, Sophie Elliott1, Praveen Honhar1, Mark Dias1, Shannan Henry1, Robert Comley2, Nabeel Nabulsi2, Yiyun Huang1, Richard Carson1, Sjoerd Finnema2, Sina Nikayin1, David Matuskey1, Sule Tinaz1, Gerard Sanacora1, *Sophie E Holmes1(1. Yale University , 2. Abbvie)
[AW2-1]Effect of daily sunshine hours on SLC6A4 promoter methylation
*Marie Spies1, Patricia Handschuh1, Matej Murgas1, Dietmar Winkler1, Dan Rujescu1, Katharina Domschke2, Rupert Lanzenberger1(1. Medical University of Vienna, 2. University of Freiburg)
[AW2-2]New targets for rapid antidepressant action and potential intervention approaches for stress-related disorders
*Ying Han1, Lin Lu2, Jie Shi1, Yuan Yao1, Dan Guo1, Fanglin Liu1(1. Peking University, 2. Peking University Sixth Hospital)
[AW2-3]Breaking Good? Repurposing Recreational Drugs to Weaken Maladaptive Reward Memories in Heavy Drinking.
*Ravi Das1(1. University College London)
[AW3-1]
*Tomoyuki Furuyashiki1(1. Kobe University Graduate School of Medicine)
[AW3-2]
*Giovanni Martinotti1(1. Department of Neuroscience, Imaging and Clinical Sciences, “G. d'Annunzio” University, Chieti, Italy)
[JCB-1]
*Pierre Blier1(1. University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada)
[JCB-2]
*Pedro Do Prado Lima1(1. Catholic University of Rio Grande do Sul)
[JCB-3]
*João Luciano De Quevedo1(1. McGovern Medical School, The University of Texas Health Science Center)
[SLS-1]
*Emmeline Edwards1(1. National Center for Complementary and Integrative Health)
[SLS-2]
*Jean King1(1. Arts & Sciences at Worcester Polytechnic Institute)
[SLS-3]
*Minae Niwa1(1. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Heersink School of Medicine)
[IS1-1]Rising to the Challenge: Emerging Approaches and Interventions for PTSD
*Lisa Burback1(1. University of Alberta)
[IS1-2]Trajectories and their risk factors of post-traumatic stress symptoms among the Japan Self-Defense Force personnel deployed to humanitarian assistance missions.
*Masanori Nagamine1, Taku Saito1, Florentine H. S. van der Does2, Masato Kitano1, Toshinori Chiba3, Naoki Edo1, Minori Koga4, Hiroyuki Toda4, Eric Vermetten2, Nic van der Wee2, Erik Giltay2(1. Division of Behavioral Science, National Defense Medical College Research Institute, Tokorozawa, Japan, 2. Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands, 3. Department of Psychiatry, Japan Self-Defense Force Hanshin Hospital, Kawanishi, Japan, 4. Department of Psychiatry, National Defense Medical College, Tokorozawa, Japan)
[IS1-3]Lessons learned from the implementation of in person scalable interventions for Ukraine’s displaced people in bordering countries (U-RISE project)
*Iryna Frankova1,2,3, Els van der Ven1,4, Anke Witteveen1, Natalie Maksymets1, Marit Sijbandij1(1. Department of Clinical, Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, 2. ARQ Centrum 45, 3. Department of Medical Psychology, Psychosomatic Medicine and Psychotherapy, Bogomolets National Medical University, 4. ARQ Nationaal Psychotrauma Centrum)
[IS2-1]New discoveries in 5-HT neuron diversity and function through large scale neurophysiological recordings
*Trevor Sharp1, Ruairi O'Sullivan1, Cheryl So1, Sophie Gullino1(1. Department of Pharmacology, University of Oxford, Oxford, UK)
[IS2-2]Serotonergic neurons in the dorsal raphe are activated by emotional salience
*Bradley Miller1(1. Columbia University)
[IS2-3]Contrasting roles of serotonin neurons in the dorsal and median raphe in positive and negative emotions
*Kazuki Nagayasu1(1. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)
[IS3-1]Prevalence of Serum Auto-Antibodies in Patients with Psychosis and/or Seizures
*Steven Siegel1, Lucas Lebozitz3, Megumi Adachi4, Jonathan Kuo2, Janet Sobell1, Mitsuyuki Matsumoto5(1. Department of Psychiatry, University of Southern California, 2. Department of Neurology, University of Southern California, 3. Department of Psychiatry, Washington University of Saint Louis, 4. Astellas , 5. Arialys )
[IS3-2]Anti-gliadin and anti-EBV antibodies in severe mental illness
*Robert H Yolken, Emily Severance1, Faith B Dickerson2(1. Johns Hopkins School of Medicine, 2. Sheppard Pratt, Baltimore Maryland)
[IS3-3]A novel targeted therapy for anti-NMDA receptor autoantibody-related disorders
*Mitsuyuki Matsumoto1, Shanni Yamaki1, Roghiye Kazimi1, Amir Razai1, Vallari Eastman1, Atsuo Kanno1, Masashi Maeda1, Satoshi Kubo1, Mathew Mitchell1, Carrolee Barlow1, Jay Lichter1(1. Arialys Therapeutics, Inc.)
[IS4-1]Alteration of salience and reward processing and (social) cognitive deficits in schizophrenia and bipolar disorder
*Huai-Hsuan Tseng1(1. National Cheng Kung University)
[IS4-2]Neurocognitive mechanisms for jumping to conclusions, cognition/metacognition, and ego-disturbance in psychosis/schizophrenia.
*Jun Miyata1(1. Aichi Medical University)
[IS4-3]Altered Resting-State Network in Adolescents with Problematic Internet Use in Indonesia
*Kristiana Siste1, Jun Miyata2, Tjhin Wiguna1, Martina Wiwie1, Jacub Pandelaki1, Kosue Tsurumi2, Hinorobu Fujiwara2,3, Toshitaka Murai2, Naoya Oishi2, Karina Kalani Firdaus1, Belinda Julivia Murtani1, Lee Thung Sen1, Rini Sekartini1(1. Faculty of Medicine, Universitas Indonesia-CiptoMangunkusumo Hospital, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. Artificial Intelligence Ethics and Society Team, RIKEN Center for Advanced Intelligence Project, Saitama, Japan)
[IS5-1]Harnessing simultaneous rTMS/fNIRS to optimize rTMS treatment efficacy
*Georg S Kranz1(1. Medical University of Vienna)
[IS5-2]Targeting cortical plasticity in drug addiction
*Ti-Fei Yuan1(1. Shanghai Mental Health Center)
[IS5-3]Potential of Maintenance Theta Burst Stimulation Therapy for Preventing Relapse after Acute Theta Burst Stimulation Therapy Response for Difficult-to-Treat Depression: A Real World Case Series
*Yoshihiro Noda1,2, Kyoshiro Fujii2, Shinichiro Nakajima1,2, Ryosuke Kitahata2(1. Keio University School of Medicine, 2. Shinjuku-Yoyogi Mental Clinic)
[IS6-1]Search for new treatment options of bipolar disorder using model mice
*Tadafumi Kato1(1. Juntendo University Graduate School of Medicine)
[IS6-2]Trimetazidine to treat the brain and the heart in bipolar depression
*Jee Hyun Kim1,2(1. Deakin University, 2. University of Melbourne)
[IS6-3]Modulating Dopamine Transporter as a therapeutic target for bipolar disorder
*Lakshmi N Yatham1(1. University of British Columbia)
[IS7-1]NMDAR antagonists disrupt hippocampal neural network firing at baseline and during working memory maintenance to alter working memory performance
*Rachel A Hill1, Chitra Vinnakota1, Matthew Hudson1, Ikeda Kazutaka2, Soichiro Ide2, Masayoshi Mishina3, Suresh Sundram1,4, Nigel Jones1(1. Monash University, 2. Tokyo Metropolitan Institute of Medical Sciences, 3. Ritsumeikan University, 4. Monash Health)
[IS7-2]The role of NMDA receptor GluN2D subunit in GABA neurons on the long-lasting antidepressant effects of ketamine enantiomers and their metabolites
*Soichiro Ide1, Yuiko Ikekubo1, Masayoshi Mishina2, Kenji Hashimoto3, Kazutaka Ikeda1(1. Tokyo Metropolitan Institute of Medical Science, 2. Ritsumeikan University, 3. Chiba University)
[IS7-3]The Role of GluN2A-Containing NMDAR in the Antidepressant Actions of Ketamine.
*Panos Zanos1, Kyle A Brown2, Polymnia Georgiou3, Peixiong Yuan4, Carlos A Zarate4, Scott M Thompson5, Todd D Gould2(1. University of Cyprus, Cyprus, 2. University of Maryland, Baltimore, USA, 3. University of Wisconsin-Milwaukee, USA, 4. National Institute of Mental Health, NIH, USA, 5. University of Colorado, Anschutz Medical Campus)
[IS8-1]Juvenile social isolation affects the development of excitatory and inhibitory neuronal circuits in medial prefrontal cortex
*Hiroki Yoshino1,2(1. Mie Prefectural Mental Medical Center, 2. Department of Psychiatry, Nara Medical University)
[IS8-2]Early social isolation stress potentiates heroin seeking by aggravating the dysfunction of prelimbic cortex to ventral tegmental area projection
*Zijun Wang1, Yunwanbin Wang1, Shuwen Yue1, Fengwei Yang2,3, Mcdonald J Stuart 1(1. University of Kansas, 2. University of Kansas Medical Center, 3. The Kansas Department of Health and Environment )
[IS8-3]Early-life stress as risk factor for Alzheimer's disease
*Aniko Korosi1(1. Swammerdam Institute for Life Sciences, Center for Neurosciences, Brain plasticity Group University of Amsterdam)
1,104 件中 ( 1 - 50 )
- 1
- ...